Dr Lalchandani Labs (BOM:541299) 3-Year Dividend Growth Rate : 0.00% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs 3-Year Dividend Growth Rate?

Dr Lalchandani Labs's Dividends per Share for the six months ended in Mar. 2024 was ₹0.00.

The historical rank and industry rank for Dr Lalchandani Labs's 3-Year Dividend Growth Rate or its related term are showing as below:

BOM:541299's 3-Year Dividend Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 10.9
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Dr Lalchandani Labs's Dividend Payout Ratio for the six months ended in Mar. 2024 was 0.00. As of today, Dr Lalchandani Labs's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Dr Lalchandani Labs's 3-Year Dividend Growth Rate

For the Diagnostics & Research subindustry, Dr Lalchandani Labs's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Lalchandani Labs's 3-Year Dividend Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Dr Lalchandani Labs's 3-Year Dividend Growth Rate falls into.

Dr Lalchandani Labs 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Dr Lalchandani Labs (BOM:541299) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Dr Lalchandani Labs's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2024 )	/	Earnings per Share (Diluted) (Q: Mar. 2024 )
	=	0	/	1.63
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Lalchandani Labs 3-Year Dividend Growth Rate Related Terms>

Dr Lalchandani Labs (BOM:541299) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048

Website

https://www.lalchandanipathlab.com

Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.

Dr Lalchandani Labs (BOM:541299) Headlines

No Headlines